Brought to you by 
HGS and SB revise their deal, admit new genomics partners
02 Aug 2001
Executive Summary
Saying their May 1993 alliance based on Human Genome Sciences' gene sequencing technology has produced far more drug leads than they can develop themselves, SmithKline Beecham and HGS have expanded and revised the terms of their collaboration.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Concluded
Deal Type
-
Alliance
- Co-Promotion
- Includes Contract
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com